WO1986004815A2 - Liquid dietary calcium supplementation - Google Patents
Liquid dietary calcium supplementation Download PDFInfo
- Publication number
- WO1986004815A2 WO1986004815A2 PCT/US1986/000314 US8600314W WO8604815A2 WO 1986004815 A2 WO1986004815 A2 WO 1986004815A2 US 8600314 W US8600314 W US 8600314W WO 8604815 A2 WO8604815 A2 WO 8604815A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- calcium
- citrate
- supplementation
- dietary
- urinary
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK497386A DK497386A (en) | 1985-02-19 | 1986-10-17 | LIQUID CALCIUM PREPARATION TO SUPPLY CALCIUM CONTENT IN THE ORGANISM |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70319685A | 1985-02-19 | 1985-02-19 | |
US703,196 | 1985-02-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1986004815A2 true WO1986004815A2 (en) | 1986-08-28 |
WO1986004815A3 WO1986004815A3 (en) | 1986-11-06 |
Family
ID=24824417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1986/000314 WO1986004815A2 (en) | 1985-02-19 | 1986-02-19 | Liquid dietary calcium supplementation |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0213181A1 (en) |
JP (2) | JPS62501843A (en) |
AU (1) | AU576950B2 (en) |
DK (1) | DK497386A (en) |
WO (1) | WO1986004815A2 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4737375A (en) * | 1985-12-26 | 1988-04-12 | The Procter & Gamble Company | Beverages and beverage concentrates nutritionally supplemented with calcium |
WO1990005713A1 (en) * | 1988-11-21 | 1990-05-31 | Board Of Regents, The University Of Texas System | Calcium supplementation by dicalcium citrate-lactate |
US5128374A (en) * | 1987-08-28 | 1992-07-07 | The Procter & Gamble Company | Use of calcium citrate malate for the treatment of osteoporosis and related disorders |
WO1995000844A1 (en) * | 1993-06-18 | 1995-01-05 | University Of Florida | Novel clinical marker and therapeutic agent in kidney stone disease and methods of use |
US5607964A (en) * | 1994-06-17 | 1997-03-04 | University Of Florida | Clinical marker and therapeutic agent in kidney stone disease and methods of use |
EP2072046A1 (en) * | 2007-12-21 | 2009-06-24 | K.F. Prof. Dr. Kopp | Use of a hydrocarbon-containing preparation for preventing or treating cardiac-circulatory diseases, diabetes, osteoporosis and chronic liver failure |
DE102010043318A1 (en) | 2010-11-03 | 2012-05-03 | Klaus F. Kopp | Calcium carbonate-containing composition |
WO2014039477A1 (en) * | 2012-09-04 | 2014-03-13 | The Board Of Regents Of The University Of Texas System | Citrate-rich calcium-magnesium supplement and uses thereof |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4772467A (en) * | 1985-02-19 | 1988-09-20 | Board Of Regents, U T Systems | Osteoporosis inhibition by dietary calcium supplementation |
FR2600893B1 (en) * | 1986-07-01 | 1990-01-12 | Sandoz Lab | NEW PHARMACEUTICAL COMPOSITIONS BASED ON CALCIUM SALTS |
JP2665764B2 (en) * | 1988-04-20 | 1997-10-22 | 日水製薬株式会社 | Calcium aqueous solution |
US7166313B2 (en) * | 2004-02-02 | 2007-01-23 | Delavau L.L.C. | Calcium fortification of bread dough |
US7927640B2 (en) | 2004-02-02 | 2011-04-19 | Delavau Llc | Calcium fortification of bread dough |
US7169417B2 (en) * | 2004-02-02 | 2007-01-30 | Delavau Llc | Calcium fortification of bread dough |
US20090130191A1 (en) | 2005-10-27 | 2009-05-21 | Sunstar Inc. | Osteoclast Growth Inhibitor, Oral Composition, and Preventive or Therapeutic Agent for Bone Diseases, Containing Liposome-Encapsulated Lactoferrin |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH193065A (en) * | 1936-11-28 | 1937-09-30 | Paul Dr Med Ourinowsky | Process for the production of a tonic which stimulates calcium binding in the human body. |
FR4384M (en) * | 1965-06-08 | 1966-08-29 | ||
EP0075429A2 (en) * | 1981-09-14 | 1983-03-30 | Philip Morris Incorporated | Dry phosphoric acid composition |
-
1986
- 1986-01-29 JP JP61501103A patent/JPS62501843A/en active Pending
- 1986-02-19 AU AU54587/86A patent/AU576950B2/en not_active Expired - Fee Related
- 1986-02-19 WO PCT/US1986/000314 patent/WO1986004815A2/en not_active Application Discontinuation
- 1986-02-19 EP EP86901627A patent/EP0213181A1/en not_active Withdrawn
- 1986-02-19 JP JP61501333A patent/JPS62501846A/en active Pending
- 1986-10-17 DK DK497386A patent/DK497386A/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH193065A (en) * | 1936-11-28 | 1937-09-30 | Paul Dr Med Ourinowsky | Process for the production of a tonic which stimulates calcium binding in the human body. |
FR4384M (en) * | 1965-06-08 | 1966-08-29 | ||
EP0075429A2 (en) * | 1981-09-14 | 1983-03-30 | Philip Morris Incorporated | Dry phosphoric acid composition |
Non-Patent Citations (2)
Title |
---|
Rote Liste 1961, Editio Cantor (Aulendorf, Wurtt., DE) "Calceno", page 146, see page 146 "Calceno" * |
Unlisted Drugs, Vol. 28, No. 9, September 1976 (Chatham, New Jersey, US) "Blemacit", page 154c, see page 154c, "Blemacit" * |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4737375A (en) * | 1985-12-26 | 1988-04-12 | The Procter & Gamble Company | Beverages and beverage concentrates nutritionally supplemented with calcium |
US5128374A (en) * | 1987-08-28 | 1992-07-07 | The Procter & Gamble Company | Use of calcium citrate malate for the treatment of osteoporosis and related disorders |
WO1990005713A1 (en) * | 1988-11-21 | 1990-05-31 | Board Of Regents, The University Of Texas System | Calcium supplementation by dicalcium citrate-lactate |
US5075499A (en) * | 1988-11-21 | 1991-12-24 | Board Of Regents, The University Of Texas System | Calcium supplementation by dicalcium citrate-lactate |
US5719138A (en) * | 1993-06-18 | 1998-02-17 | University Of Florida | Method for complexing a free metal ion |
WO1995000844A1 (en) * | 1993-06-18 | 1995-01-05 | University Of Florida | Novel clinical marker and therapeutic agent in kidney stone disease and methods of use |
US5550259A (en) * | 1993-06-18 | 1996-08-27 | The University Of Florida | Clinical marker and therapeutic agent in kidney stone disease and methods of use |
US5601804A (en) * | 1993-06-18 | 1997-02-11 | The University Of Florida | Dicitrate cyclic diester dentifrice |
US5604103A (en) * | 1993-06-18 | 1997-02-18 | University Of Florida | Kit for detection of clinical marker in kidney stone disease |
US5607964A (en) * | 1994-06-17 | 1997-03-04 | University Of Florida | Clinical marker and therapeutic agent in kidney stone disease and methods of use |
EP2072046A1 (en) * | 2007-12-21 | 2009-06-24 | K.F. Prof. Dr. Kopp | Use of a hydrocarbon-containing preparation for preventing or treating cardiac-circulatory diseases, diabetes, osteoporosis and chronic liver failure |
DE102010043318A1 (en) | 2010-11-03 | 2012-05-03 | Klaus F. Kopp | Calcium carbonate-containing composition |
WO2012059543A1 (en) | 2010-11-03 | 2012-05-10 | Kopp Klaus F | Composition containing calcium carbonate |
WO2014039477A1 (en) * | 2012-09-04 | 2014-03-13 | The Board Of Regents Of The University Of Texas System | Citrate-rich calcium-magnesium supplement and uses thereof |
US9539283B2 (en) | 2012-09-04 | 2017-01-10 | The Board Of Regents Of The University Of Texas System | Citrate-rich calcium-magnesium supplement and uses thereof |
US10092593B2 (en) | 2012-09-04 | 2018-10-09 | The Board Of Regents Of The University Of Texas System | Citrate-rich calcium-magnesium supplement and uses thereof |
EP3653061A1 (en) * | 2012-09-04 | 2020-05-20 | The Board of Regents of the University of Texas System | Citrate-rich calcium-magnesium supplement and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
EP0213181A1 (en) | 1987-03-11 |
JPS62501843A (en) | 1987-07-23 |
DK497386A (en) | 1986-12-15 |
AU576950B2 (en) | 1988-09-08 |
WO1986004815A3 (en) | 1986-11-06 |
JPS62501846A (en) | 1987-07-23 |
AU5458786A (en) | 1986-09-10 |
DK497386D0 (en) | 1986-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4851221A (en) | Liquid calcium supplementation from readily soluble mixtures of calcium compound and citric acid | |
AU576950B2 (en) | Liquid dietary calcium supplementation | |
US4772467A (en) | Osteoporosis inhibition by dietary calcium supplementation | |
US5654011A (en) | Dietary supplements | |
US5807586A (en) | Method of dietary supplementation | |
US20020197330A1 (en) | Method of dietary supplementation | |
CA2376017C (en) | Potassium calcium citrate compositions and methods for production | |
US8216614B2 (en) | Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis | |
Koide et al. | Conservative treatment of cystine calculi: effect of oral alpha-mercaptopropionylglycine on cystine stone dissolution and on prevention of stone recurrence | |
KR0163583B1 (en) | Treatment of hypertension by oral administration of potassium bicarbonate | |
PATTARAS et al. | Citrate in the management of urolithiasis | |
US20040048925A1 (en) | Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives | |
JPH10513162A (en) | Agents acting on bone formation diseases | |
US20040220266A1 (en) | Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives | |
JPH05501405A (en) | Phosphate binder for oral administration | |
JP3486755B2 (en) | Hyperphosphatemia preventive / therapeutic agent | |
WO2005096846A1 (en) | Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives | |
US20220175828A1 (en) | Liquid concentrates of calcium and magnesium | |
KR20230151980A (en) | Effervescent drug formulation | |
Peterson | Urinary tract calculi associated with enteritis and intestinal bypass | |
Ushkalova | What drugs are antacids? Antacids: principle of action, examples, indications for use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AT AU BB BG BR CH DE DK FI GB HU JP KP KR LK LU MC MG MW NL NO RO SD SE SU US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CF CG CH CM DE FR GA GB IT LU ML MR NL SE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1986901627 Country of ref document: EP |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AT AU BB BG BR CH DE DK FI GB |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CF CG CH CM DE FR GA GB |
|
WWP | Wipo information: published in national office |
Ref document number: 1986901627 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1986901627 Country of ref document: EP |